Clinical Trials - March 29, 2015
Spinach Extract Aids Weight Loss
A study conducted at Lund University by lead researcher Charlotte Erlanson-Albertsson, MD, PhD found that people who were trying to lose weight and used the spinach extract Appethyl daily lost more than 40 percent more weight than those who took a placebo. In this clinical trial, overweight women either took a daily five gram dose of […]
Collaboration - March 28, 2015
Astra, Innate Sign Agreement
Innate Pharma has signed a co-development and commercialization agreement with AstraZeneca and MedImmune, AstraZeneca’s wholly-owned subsidiary. The deal focuses on the development of anti-NKG2A antibody, IPH2201, also in combination with MEDI4736, an anti-PD-L1 immune checkpoint inhibitor created by MedImmune, to fight cancer. The compound IPH2201 currently is in Phase II development. Under the terms of […]
Clinical Trials - March 27, 2015
Novo to Resubmit Drugs to FDA
Novo Nordisk has decided to resubmit the prespecified interim analysis of DEVOTE as part of a Class II Resubmission of the New Drug Applications (NDAs) of Tresiba® and Ryzodeg® to the US Food and Drug Administration (FDA). The resubmission is expected to take place within the next month, according to the company. The cardiovascular outcomes trial for […]
Uncategorized - March 27, 2015
“Cocktail” Effect Raises Risks
A new study has found that the carcinogenic effect of a cocktail of substances is greater than the effect of the individual substances added together. This would mean that government regulations pertaining to the levels of toxic substances in foods are probably inadequate. “Our study shows that if we don’t take the cocktail effect into […]
Uncategorized - March 26, 2015
Diabetic Pancreas Cells Recover
Pancreases of patients with type 1 diabetes can regain the ability to produce insulin when cells are given the chance to recover outside the body, researchers have demonstrated. Professor Knut Dahl-Jørgensen and doctoral student Lars Krogvold at the University of Oslo are leading a research project (DiViD) to try to determine, among other things, if […]
Uncategorized - March 26, 2015
AZ Creates Scientific Review Bd.
AstraZeneca PLC has created a scientific review board to assess requests from external researchers to access patient-level data. The board of independent clinicians and academics has been developed as a part of the company’s commitment to groups including the European Federation of Pharmaceutical Industries and Associations, Pharmaceutical Research and Manufacturers of America Responsible Data Sharing […]
